HCA Healthcare Inc header image

HCA Healthcare Inc

HCA

Equity

ISIN US40412C1018 / Valor 11321027

New York Stock Exchange, Inc (2024-09-17)
USD 397.50-1.47%

HCA Healthcare Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

HCA Healthcare Inc is a for-profit operator of healthcare facilities, including hospitals and surgery centers.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Revenue Growth

HCA Healthcare Inc. reported revenues totaling $17.492 billion for the second quarter of 2024, a significant increase from $15.861 billion in the second quarter of 2023. This growth reflects a strong demand for the company's healthcare services.

Net Income

For the second quarter of 2024, HCA Healthcare Inc. achieved a net income attributable to the company of $1.461 billion, or $5.53 per diluted share. This is an improvement from the $1.193 billion, or $4.29 per diluted share, reported in the same quarter of the previous year.

Adjusted EBITDA

HCA Healthcare Inc.'s Adjusted EBITDA for the second quarter of 2024 was $3.550 billion, compared to $3.056 billion in the second quarter of 2023. This non-GAAP financial measure indicates the company's strong operational performance.

Admissions and Surgeries

Same facility admissions for HCA Healthcare Inc. increased by 5.8 percent in the second quarter of 2024 compared to the same period in 2023. However, while same facility inpatient surgeries increased by 2.6 percent, same facility outpatient surgeries saw a decline of 2.1 percent.

Dividend Announcement

HCA Healthcare Inc. declared a quarterly cash dividend of $0.66 per share on its common stock, payable on September 30, 2024, to stockholders of record at the close of business on September 16, 2024. Future dividends will depend on the company's financial condition and results of operations.

Summarized from source with an LLMView Source

Key figures

55.1%1Y
53.6%3Y
218%5Y

Performance

23.7%1Y
31.0%3Y
38.0%5Y

Volatility

Market cap

102584 M

Market cap (USD)

Daily traded volume (Shares)

398,967

Daily traded volume (Shares)

1 day high/low

404.84 / 396.12

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Dr Reddy'S Laboratories Ltd
Dr Reddy'S Laboratories Ltd Dr Reddy'S Laboratories Ltd Valor: 1221723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.19%USD 79.53
Gyre Therapeutics Inc
Gyre Therapeutics Inc Gyre Therapeutics Inc Valor: 130270397
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.14%USD 14.04
CryoPort Inc
CryoPort Inc CryoPort Inc Valor: 28284615
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.21%USD 8.39
elf Beauty Inc
elf Beauty Inc elf Beauty Inc Valor: 33775016
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.67%USD 112.43
Conmed Corp
Conmed Corp Conmed Corp Valor: 920278
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.21%USD 74.80
Douglas AG
Douglas AG Douglas AG Valor: 133507391
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.21%EUR 19.46
Pharma Mar SA
Pharma Mar SA Pharma Mar SA Valor: 56130572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.00%EUR 42.84
Beximco Pharmaceuticals Ltd
Beximco Pharmaceuticals Ltd Beximco Pharmaceuticals Ltd Valor: 2318407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%GBP 0.21
Sareum Holdings PLC
Sareum Holdings PLC Sareum Holdings PLC Valor: 116566624
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.59%GBP 0.27
ACELYRIN INC
ACELYRIN INC ACELYRIN INC Valor: 126441937
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.62%USD 4.38